glp-1/gip agonists Major physiological roles of GLP-1 and GIP. Tirzepatide is acting as an Schematic illustration of monoagonists, dual

Our findings align with these previous studies, leading us to hypothesize that GSH levels are higher in the tumor tissues of chemotherapy-resistant breast cancer patients compared to chemotherapy-sensitive patients

According to the National Health Center of PTSD in the US, it is estimated that 3.5% of the US population (more than 11 million Americans) suffers from PTSD in a given year, but less than half of these patients are in proper treatment, and less than half of those in treatment receive minimally adequate care (Wang et al., 2005)

For people who experience withdrawal effects or weight regain after stopping GLP-1 therapy , the amount of muscle preserved during treatment directly influences their trajectory

The FDA is reconsidering its 2023 ban on certain injectable peptides with advisory review starting in July, opening the door to compounding if cleared

Weeks 6-8 : Peak benefits start kicking in

This water-soluble tripeptide, made from the amino acids glycine, cysteine and glutamic acid, supports the cells in detoxification and helps protect them from damage caused by free radicals